Menu
GeneBe

rs61744512

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_024009.3(GJB3):c.579C>T(p.Gly193=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00102 in 1,613,762 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0050 ( 5 hom., cov: 32)
Exomes 𝑓: 0.00060 ( 9 hom. )

Consequence

GJB3
NM_024009.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -3.06
Variant links:
Genes affected
GJB3 (HGNC:4285): (gap junction protein beta 3) This gene is a member of the connexin gene family. The encoded protein is a component of gap junctions, which are composed of arrays of intercellular channels that provide a route for the diffusion of low molecular weight materials from cell to cell. Mutations in this gene can cause non-syndromic deafness or erythrokeratodermia variabilis, a skin disorder. Alternative splicing results in multiple transcript variants encoding the same protein. [provided by RefSeq, Jul 2008]
SMIM12 (HGNC:25154): (small integral membrane protein 12) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 1-34785341-C-T is Benign according to our data. Variant chr1-34785341-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 46085.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-34785341-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-3.06 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00497 (757/152198) while in subpopulation AFR AF= 0.0161 (669/41542). AF 95% confidence interval is 0.0151. There are 5 homozygotes in gnomad4. There are 341 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
High AC in GnomAd at 756 AD,Digenic gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GJB3NM_024009.3 linkuse as main transcriptc.579C>T p.Gly193= synonymous_variant 2/2 ENST00000373366.3
GJB3NM_001005752.2 linkuse as main transcriptc.579C>T p.Gly193= synonymous_variant 2/2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GJB3ENST00000373366.3 linkuse as main transcriptc.579C>T p.Gly193= synonymous_variant 2/21 NM_024009.3 P1
GJB3ENST00000373362.3 linkuse as main transcriptc.579C>T p.Gly193= synonymous_variant 2/21 P1
SMIM12ENST00000426886.1 linkuse as main transcriptc.208-66932G>A intron_variant, NMD_transcript_variant 1
ENST00000542839.1 linkuse as main transcriptn.110+2647G>A intron_variant, non_coding_transcript_variant 5

Frequencies

GnomAD3 genomes
AF:
0.00497
AC:
756
AN:
152080
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0161
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00406
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000250
Gnomad OTH
AF:
0.00432
GnomAD3 exomes
AF:
0.00155
AC:
389
AN:
251386
Hom.:
7
AF XY:
0.00121
AC XY:
164
AN XY:
135850
show subpopulations
Gnomad AFR exome
AF:
0.0180
Gnomad AMR exome
AF:
0.00185
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000202
Gnomad OTH exome
AF:
0.00130
GnomAD4 exome
AF:
0.000604
AC:
883
AN:
1461564
Hom.:
9
Cov.:
34
AF XY:
0.000554
AC XY:
403
AN XY:
727080
show subpopulations
Gnomad4 AFR exome
AF:
0.0156
Gnomad4 AMR exome
AF:
0.00197
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000154
Gnomad4 OTH exome
AF:
0.00161
GnomAD4 genome
AF:
0.00497
AC:
757
AN:
152198
Hom.:
5
Cov.:
32
AF XY:
0.00458
AC XY:
341
AN XY:
74414
show subpopulations
Gnomad4 AFR
AF:
0.0161
Gnomad4 AMR
AF:
0.00405
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000250
Gnomad4 OTH
AF:
0.00427
Alfa
AF:
0.00272
Hom.:
3
Bravo
AF:
0.00581
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.000273
EpiControl
AF:
0.000178

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMay 07, 2012Gly193Gly in Exon 02 of GJB3: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue, is not located within the splice consensus sequence, and has been identified in 2.0% (73/3738) of Afr ican American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs61744512). -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxSep 23, 2019This variant is associated with the following publications: (PMID: 15131355) -
Benign, criteria provided, single submitterclinical testingInvitaeDec 01, 2023- -
Autosomal recessive nonsyndromic hearing loss 1A;C2675236:Autosomal dominant nonsyndromic hearing loss 2B;C4551486:Erythrokeratodermia variabilis et progressiva 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsJul 30, 2021- -
Erythrokeratodermia variabilis et progressiva 1 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
Cadd
Benign
3.6
Dann
Benign
0.77

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61744512; hg19: chr1-35250942; COSMIC: COSV64904843; API